Trial intelligence / Profile preview

Conventional vs Intensive Insulin Therapy in Children with Type 1 Diabetes

NCT00206401Phase 4Completed

Sponsor
Baylor College of Medicine
Start
Nov 2004
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin glargine in type 1 diabetes mellitus (T1D), sponsored by Baylor College of Medicine. Started Nov 2004; status: completed.

02

Drugs

insulin glargine
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00206401.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00206401.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call